Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 5 (3) , 163-170
- https://doi.org/10.1016/s0168-8227(88)80083-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Serum type III procollagen peptide: Indicator for pulmonary fibrosis: II. Application in 80 asbestos insulation workersAmerican Journal of Industrial Medicine, 1987
- Serum levels of laminin as a tool of detection for irreversibility of hepatic fibrosis in patients with alcoholic liver disease.Kanzo, 1987
- Concentrations of 7S collagen and laminin P1 in sera of patients with diabetes mellitusJournal of Molecular Medicine, 1986
- Serum type III procollagen peptide : Indicator for pulmonary fibrosis. I A tool for early detection of pulmonary fibrosis as a complication in cancer therapy.The Keio Journal of Medicine, 1986
- Type IV collagen and laminin‐related antigens in human serum in alcoholic liver diseaseEuropean Journal of Clinical Investigation, 1985
- Protease Resistance and Conformation of LamininEuropean Journal of Biochemistry, 1982
- Laminin and epithelial cell attachmentNature, 1981
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- Diabetes and atherosclerosis ? The role of insulinDiabetologia, 1979
- Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patientsJournal of Clinical Investigation, 1968